| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
S4 Consultants is a San Jose, CA-based company in the Software & Internet sector.
Providing third-party support, managed services, and consulting for organizations running SAP, Oracle, and Salesforce enterprise software.
softchoice corp is a Chicago, IL-based company in the Software and Internet sector.
BA Insight`s software portfolio accelerates and future-proofs the creation of cloud-based and on-premise SharePoint portals for enterprises, transforming how users find information. Our software dramatically reduces the time, cost, effort, and risk of implementing SharePoint portals while providing a greatly improved user experience. Customers use our applications to improve productivity by finding the right information faster using Smart Previews and User-Generated InfoSites; our classification software to increase findability using auto-tagging, metadata generation, and text analytics; and our pre-built connectors and federation to provide secure connectivity to a wide variety of content systems.